Australia’s Largest Christian News Site

Nebraska’s Attorney General has officially given the green light to licensed doctors in Nebraska to prescribe the drugs Ivermectin and Hydroxychloroquine for the treatment or prevention of COVID-19.

Dr Anthony Fauci and other mainstream public health officials have faced significant criticism during this pandemic: their overwhelming push to give everyone at least two to three mRNA COVID shot doses overlooks the potential benefit of other therapeutics that could help treat or even prevent COVID-19.

This criticism is especially valid given that many of these therapeutics have been prescribed to humans for decades, unlike the brand new COVID-19 jab.

Courage in the Face of Widespread Denouncement

From former President Donald Trump to comedian Joe Rogan, public figures – along with experienced scientists and medical experts – who have expressed an interest in COVID-19 interventions that weren’t the jab are quickly denounced by the media. With this in mind, the recent decision by the Nebraska Attorney General seems to be exceptionally courageous.

On October 14th, 2021, the Office of the Attorney General of the State of Nebraska released an opinion regarding the “Prescription of Ivermectin or Hydroxychloroquine as Off-Label Medicines for the Prevention or Treatment of COVID-19.”

Along with his colleagues, Nebraska’s AG, Douglas J. Peterson officially gave the green light to licensed doctors in Nebraska to prescribe the drugs Ivermectin and Hydroxychloroquine for the treatment or prevention of COVID-19. Doctors are now free to make use of off-label prescribing as they see fit, a common and legal practice among prescribing physicians.

The Nebraska Attorney General’s Decision

In the opinion, AG Peterson brings up several salient points regarding his decision – first, pointing to the questionable “science” that has been used to lambast Hydroxychloroquine. “[W]e have found significant controversy and suspect information about potential COVID-19 treatments,” the release says.

A striking example features one of the world’s most prestigious medical journals – the Lancet. In the middle of the COVID-19 pandemic, The Lancet published a paper denouncing Hydroxychloroquine as dangerous.

Yet, the reported statistics were so flawed that journalists and outside researchers immediately began raising concerns. Then after one of the authors refused to provide the analysed data, the paper was retracted, but not before many countries stopped using Hydroxychloroquine and trials were canceled or interrupted.

When fraudulent information is published in a leading medical journal, it understandably leads to skepticism in some physicians and members of the public.

Per the Nebraska AG:

The available data does not justify filing disciplinary actions against physicians simply because they prescribe Ivermectin or Hydroxychloroquine to prevent or treat COVID-19. If, on the other hand, healthcare providers neglect to obtain informed consent, deceive their patients, prescribe excessively high doses, fail to check for contraindications, or engage in other misconduct, they might be subject to discipline.

A Precedent For Other Jurisdictions

The AG also opened the door to other off-label drugs that might show promise, “either now or in the future.”

It is a true spot of hope to hear that doctors who are willing to offer evidence-backed therapies to their patients with COVID-19 will not be threatened in some parts of this country. However, time will tell if other government officials will follow this state department’s lead.

Originally published at NaturalHealth365. Image by RODNAE Productions at Pexels.